Stable formulations of linaclotide
US10675325B2 · kind B2 · utility
0Cited by
42References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 26, 2019 |
| Grant date | Jun 9, 2020 |
| Priority date | — |
| Expiry date | Sep 26, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to stable pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.